InvestorsHub Logo
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 21

Monday, 11/14/2016 9:21:59 AM

Monday, November 14, 2016 9:21:59 AM

Post# of 53
CLCD has enrolled >50% of 2,968 target in SPARTAN phase-3 trial:

http://finance.yahoo.com/news/colucid-pharmaceuticals-provides-spartan-enrollment-130000943.html

Please see #msg-124979400 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”